Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NOVO-B
Ранг среди акций #107
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Цена акции
$41.14
Последняя синхронизация: 2026-09-21
Рыночная капитализация
$182.76B
Изменение (1 день)
-7.78%
Изменение (1 год)
-32.24%
Страна
DK
Торговля Novo Nordisk A/S (NOVO-B)

Категория

Выручка компании Novo Nordisk A/S (NOVO-B)
Выручка на Jun 2026 TTM: $52.30B
Согласно последним финансовым отчетам Novo Nordisk A/S, текущая выручка компании (TTM) составляет $52.30B. В 2024 году компания получила выручку $40.52B больше, чем выручке в 2023 году, которая составила $34.39B. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки Novo Nordisk A/S с 2000 по 2026
Выручка на конец каждого года
Год Выручка Изменить
2026 (TTM) $52.30B 12.04%
2025 $46.68B 15.22%
2024 $40.52B 17.82%
2023 $34.39B 35.02%
2022 $25.47B 18.29%
2021 $21.53B 3.33%
2020 $20.84B 13.79%
2019 $18.31B 6.63%
2018 $17.17B -4.59%
2017 $18.00B 13.46%
2016 $15.86B 0.88%
2015 $15.73B 8.89%
2014 $14.44B -6.28%
2013 $15.41B 11.69%
2012 $13.80B 19.42%
2011 $11.55B 6.01%
2010 $10.90B 10.52%
2009 $9.86B 15.53%
2008 $8.54B 3.65%
2007 $8.24B 20.44%
2006 $6.84B 28.15%
2005 $5.34B -0.14%
2004 $5.34B 18.51%
2003 $4.51B 27.01%
2002 $3.55B 25.45%
2001 $2.83B 9.05%
2000 $2.60B 0.00%
Выручка аналогичных компаний или конкурентов
Компания Выручка Разница в выручке Страна
$79.67B 52.31%
US
$97.93B 87.23%
US
$64.39B 23.10%
US
$77.52B 48.21%
CH
$66.40B 26.95%
US